News

July 30, 2014 — Covidien announced the commercial launch of its next-generation Trellis peripheral infusion system. The redesigned system continues to be the only pharmacomechanical thrombolysis...

Each year, deep vein thrombosis (DVT) leads to hospitalization for approximately 250,000 Americans, and often leads to serious — and even fatal —complications. Fortunately, at the...

CleanerXT Argon Medical Devices Inc. Thrombectomy Devices Deep Vein Thrombosis

Argon Medical Devices Inc. began marketing the CelanerXT rotational thrombectomy system as a new addition to the Cleaner family of dialysis products. 

Society of Interventional Radiology SIR Deep Vein Thrombosis DVT PTS Venous

Deep vein thrombosis (DVT) often brings with it the risk of post-thrombotic syndrome (PTS), an under-recognized but...

A large-scale analysis assessing the real-world risk of venous thromboembolism (VTE) in chemotherapy patients...

cardiovascular ultrasound systems thrombectomy bubbles thrombosis

Ultrasound-stimulated microbubbles have been showing promise in recent years as a non-invasive method of...

Aspire Thrombectomy Device Aspiration Medical

Nick Cavros, interventional cardiologist with Cardiovascular Institute of the South (CIS) at Lafayette General Medical Center in Lafayette, La., used a new hand-held mechanical aspiration system...

July 22, 2013 — A new report issued by the American College of Cardiology (ACC) and developed in collaboration with 10 other professional societies provides detailed criteria to help clinicians...

Bayer AngioJet DVT

Catheter-based thrombectomy systems are increasingly being used to remove blood clots from vessels inside the body, often as an adjunct therapy to systemic pharmaceutical thrombolytics. ...

Bathing dangerous blood clots in special medication, breaking them up with jets of saline and vacuuming them out of the body is a fast, effective method of treating deep vein thrombosis (DVT),...

Stryker announced the global commercial launch of the new Trevo ProVue Retriever. The Trevo ProVue Retriever is the first clot removal device fully visible during the procedure for precise...

Xarelto rivaroxaban Janssen Pharmaceuticals Deep Vein Thromosis Treament

Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved rivaroxaban (Xarelto), an oral anticoagulant, for the...

Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted...

January 23, 2012 — Pregnant women who develop dangerous blood clots in the leg often forgo the most effective treatment for fear of harming the baby. Yet treatment to remove the clot is not only...

November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post-dilation of nitinol stents using CryoPlasty therapy with the PolarCath...

May 3, 2011 – Being tall and obese may increase your risk for potentially dangerous blood clots, according to new research in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the...

April 4, 2011 – Doctors are encouraged to consider therapies in addition to blood thinners to treat certain patients with potentially dangerous blood clots that form in the deep veins and travel...

March 25, 2011 – A new, next-generation aspiration catheter has been introduced in the United States. The Fetch 2 Catheter, by Medrad Interventional, features a flexible, variable pitch coiled...

March 7, 2011 – Each year between 100,000 and 180,000 Americans die as the result of pulmonary embolism, a complication from blood clots in the lungs. The Vascular Disease Foundation urges...

February 7, 2011 – There is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors...